Neurological deterioration in acute lacunar infarctions: The role of excitatory and inhibitory neurotransmitters

Stroke

Volumn 32, Issue 5, 2001, Pages 1154-1161

  Serena, Joaquín ^a   Leira, Rogelio ^b   Castillo, José ^b   Pumar, José Manuel ^b   Castellanos, Mar ^a   Dávalos, Antoni ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Excitotoxicity; GABA; Glutamates; Lacunar infarction; Stroke, acute

Indexed keywords

4 AMINOBUTYRIC ACID; EXCITATORY AMINO ACID RECEPTOR; EXCITOTOXIN; GLUTAMIC ACID; GLYCINE; NEUROTRANSMITTER;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PLASMA; PREDICTION; PRIORITY JOURNAL;

EID: 0034840055     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.5.1154     Document Type: Article

References (35)

1. Ischemic stroke subtypes a population-based study of functional outcome, survival, and recurrence
2. Lacunar strokes and infarcts: A review
3. Pure motor hemiplegia: CT study of 30 cases
4. Lacunar infarcts: Clinical and computed tomographic correlations
5. Progressive stroke caused by CT-verified small deep infarcts: Relation with the size of the infarct and clinical outcome
6. Clinical features of progressive lacunar infarction: Retrospective analysis of patients with motor syndromes
7. Progressive motor deficits in lacunar infarction
8. Different predictors of neurological worsening in different causes of stroke
9. Neuroprotection for acute stroke: Making clinical trials work
10. Acute stroke therapy at the millennium: Consummating the marriage between the laboratory and bedside: The Feinberg Lecture
11. Progression of ischemic stroke and excitotoxic amino acids
12. The natural history of lacunar infarction: The Oxfordshire Community Stroke Project
13. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke
14. The Canadian Neurological Scale: Validation and reliability assessment
15. Deteriorating ischemic stroke: Risk factors and prognosis
16. Arterial territories of the human brain: Cerebral hemispheres
17. Source arterial territories of human brain
18. The need to quantify right-to-left shunt in acute ischemic stroke: A case-control study
19. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial, TOAST: Trial of Org 10172 in Acute Stroke Treatment
20. Excitotoxic index: A biochemical marker of selective vulnerability
21. Formulas for threshold computations
22. Mechanism in progressive lacunar infarction: A case report with magnetic resonance imaging
23. Progressing stroke
24. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: Correlation with histopathology
25. Duration of glutamate release after acute ischemic stroke
26. Neurotransmitters and pathophysiology of stroke: Evidence for the release of glutamate and other transmitters/mediators in animal and humans
27. Serum amino acid levels after permanent middle cerebral artery occlusion in the rat
28. Recent clinical and basic advances in white matter ischemia
29. Anatomy and physiology of glutamate in the CNS
30. GABA and neuroprotection
31. Striatal outflow of adenosine, excitatory amino acids, γ-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: Correlation with neurological deficit and histopathological damage
32. Intracerebral human microdialysis: In vivo study of an acute focal ischemic model of the human brain
33. The role of gama aminobutyric acid (GABA) in acute ischemic stroke
34. Molecular signatures of neurotoxicity in cardiac surgery with cardiopulmonary bypass
35. Endogenous GABA attenuates CNS white matter dysfunction following anoxia